SLC7A11 and hepatocellular carcinoma: SLC7A11‐AS1 enhances the stability of SLC7A11 mRNA by forming an RNA–RNA double‐stranded structure, promoting SLC7A11 expression and thereby inhibiting ferroptosis and promoting tumorigenesis of HCC in vitro and vivo.